Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines

Johannes Boltze*, Daniel Christoph Wagner, Nils Henninger, Nikolaus Plesnila, Cenk Ayata

*Corresponding author for this work
11 Citations (Scopus)


The multicenter phase III preclinical trial concept is currently discussed to enhance the predictive value of preclinical stroke research. After public announcement, we collected a community feedback on the concept with emphasis on potential design features and guidelines by an anonymous survey. Response analysis was conducted after plausibility checks by applying qualitative and quantitative measures. Most respondents supported the concept, including the implementation of a centralized steering committee. Based on received feedback, we suggest careful, stepwise implementation and to leave selected competencies and endpoint analysis at the discretion of participating centers. Strict application of quality assurance methods is accepted, but should be harmonized. However, received responses also indicate that the application of particular quality assurance models may require more attention throughout the community. Interestingly, clear and pragmatic preferences were given regarding publication and financing, suggesting the establishing of writing committees similar to large-scale clinical trials and global funding resources for financial support. The broad acceptance among research community encourages phase III preclinical trial implementation.

Original languageEnglish
JournalTranslational Stroke Research
Issue number4
Pages (from-to)241-247
Number of pages7
Publication statusPublished - 01.08.2016


Dive into the research topics of 'Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines'. Together they form a unique fingerprint.

Cite this